Recipharm Re6.7 billion acquisition of 74% stake in Nitin Lifesciences

20/10/2015

Private acquisition

Value:

Re 6.7 billion

Dollar value:

$ 103 million

Status:

Completed

Date:

20/10/2015

Overview:

Recipharm has acquired a 74% stake in Nitin Lifesciences for Re6.7 billion.
Nitin Lifesciences manufactures sterile injectibles.
Recipharm is a Swedish pharmaceutical company.

Katrin Kostadinova - Data analyst

Jurisdictions:

India
Sweden

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

India

Industry sector:

Pharmaceuticals and life sciences

Firms:

Khaitan & Co

Party: Nitin Lifesciences (Target)

Lawyer: Kalpana Unadkat

Veritas Legal

Party: Recipharm AB (Acquirer)

Related deals